HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights…
| Price | $50.97 |
|---|---|
| Market cap | $4.4B |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| Exchange | NASDAQ |
| 52-week range | 20.13-52.2212 |
| Beta | 2.02 |
Explore HTFL's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.